InnoVein LLC — SEC Form D Filing

InnoVein LLC filed an SEC Form D on June 26, 2026, reporting $375K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 26, 2026
Amount reported
$375K
Round stage
Series A
Industry
Medical Devices

What the company does

Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: NEVADA

Problem

Existing medical options for venous insufficiency are limited, leaving many patients without effective treatment.

Solution

InnoVein develops a novel, implantable replacement valve designed to restore proper venous function.

Verdict

Investors funded InnoVein primarily due to the potential for a novel, implantable device to address a persistent, undertreated medical condition, not because of a clear path to market or identified buyer. This implicitly bet on the technical feasibility of the implant and its regulatory approval path. Upside was limited by the significant R&D and clinical trial hurdles typical for Class III medical devices, and the absence of a defined go-to-market strategy beyond the innovation itself.

Source: SEC EDGAR Form D filing